Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

620 ARTÍCULOS , VIENDO DEL 526 AL 540

Sigma ligands as potent inhibitors of Aβ and AβOs in neurons and promising therapeutic agents of Alzheimer's disease

Ma WH, Chen AF, Xie XY, Huang YS.

Neuropharmacology. 2021 Jun 1;190:108342. doi: 10.1016/j.neuropharm.2020.108342. Epub 2020 Oct 9.

The structure and phase of tau: from monomer to amyloid filament

Zeng Y, Yang J, Zhang B, Gao M, Su Z, Huang Y.

Cell Mol Life Sci. 2021 Mar;78(5):1873-1886. doi: 10.1007/s00018-020-03681-x. Epub 2020 Oct 19.

Structure and therapeutic uses of butyrylcholinesterase: Application in detoxification, Alzheimer's disease, and fat metabolism

Xing S, Li Q, Xiong B, Chen Y, Feng F, Liu W, Sun H.

Med Res Rev. 2021 Mar;41(2):858-901. doi: 10.1002/med.21745. Epub 2020 Oct 25.

Critical thinking on amyloid-beta-targeted therapy: challenges and perspectives

Sun BL, Chen Y, Fan DY, Zhu C, Zeng F, Wang YJ.

Sci China Life Sci. 2021 Jun;64(6):926-937. doi: 10.1007/s11427-020-1810-y. Epub 2020 Oct 23.

Iron and Ferroptosis as Therapeutic Targets in Alzheimer's Disease

Gleason A, Bush AI.

Neurotherapeutics. 2021 Jan;18(1):252-264. doi: 10.1007/s13311-020-00954-y. Epub 2020 Oct 27.

Small molecule therapeutics for tauopathy in Alzheimer's disease: Walking on the path of most resistance

Wang L, Bharti, Kumar R, Pavlov PF, Winblad B.

Eur J Med Chem. 2021 Jan 1;209:112915. doi: 10.1016/j.ejmech.2020.112915. Epub 2020 Oct 15.

Novel target for treating Alzheimer's Diseases: Crosstalk between the Nrf2 pathway and autophagy

Zhang W, Feng C, Jiang H.

Ageing Res Rev. 2021 Jan;65:101207. doi: 10.1016/j.arr.2020.101207. Epub 2020 Nov 1.

Antimicrobial therapy and the potential mechanisms in Alzheimer's disease

Song X, Chen J, Hou Z, Xie N.

Neurosci Lett. 2021 Jan 10;741:135464. doi: 10.1016/j.neulet.2020.135464. Epub 2020 Nov 6.

Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer's disease

Kesika P, Suganthy N, Sivamaruthi BS, Chaiyasut C.

Life Sci. 2021 Jan 1;264:118627. doi: 10.1016/j.lfs.2020.118627. Epub 2020 Oct 22.

Tacrines as Therapeutic Agents for Alzheimer's Disease. V. Recent Developments

Bautista-Aguilera ÓM, Ismaili L, Iriepa I, Diez-Iriepa D, Chabchoub F, Marco-Contelles J, Pérez M.

Chem Rec. 2021 Jan;21(1):162-174. doi: 10.1002/tcr.202000107. Epub 2020 Nov 10.

CD36 in Alzheimer's Disease: An Overview of Molecular Mechanisms and Therapeutic Targeting

Dobri AM, Dudău M, Enciu AM, Hinescu ME.

Neuroscience. 2021 Jan 15;453:301-311. doi: 10.1016/j.neuroscience.2020.11.003. Epub 2020 Nov 17.

The Interplay of ABC Transporters in Aβ Translocation and Cholesterol Metabolism: Implicating Their Roles in Alzheimer's Disease

Behl T, Kaur I, Sehgal A, Kumar A, Uddin MS, Bungau S.

Mol Neurobiol. 2021 Apr;58(4):1564-1582. doi: 10.1007/s12035-020-02211-x. Epub 2020 Nov 19.

The essential elements of Alzheimer's disease

Lei P, Ayton S, Bush AI.

J Biol Chem. 2021 Jan-Jun;296:100105. doi: 10.1074/jbc.REV120.008207. Epub 2020 Nov 27.

Exploring the role of mitochondrial proteins as molecular target in Alzheimer's disease

Chadha S, Behl T, Sehgal A, Kumar A, Bungau S.

Mitochondrion. 2021 Jan;56:62-72. doi: 10.1016/j.mito.2020.11.008. Epub 2020 Nov 19.

What are the difficulties of implementing innovative pharmacy practice models in the care of patients with dementia?

Wimo A.

Expert Rev Pharmacoecon Outcomes Res. 2021 Feb;21(1):1-4. doi: 10.1080/14737167.2021.1848551. Epub 2020 Nov 26.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias